Evidence map›Paper›PMID 25133155›Full record

ArticleWorld journal of clinical cases2014

Rare large homozygous CFTR gene deletion in an Iranian patient with cystic fibrosis.

Shirin Farjadian, Mozhgan Moghtaderi, Roberta Zuntini, Simona Ferrari

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shirin FarjadianShirin Farjadian, Department of Immunology, Allergy Research Center, Shiraz University of Medical Sciences, 71348-45794 Shiraz, Iran.
Mozhgan MoghtaderiShirin Farjadian, Department of Immunology, Allergy Research Center, Shiraz University of Medical Sciences, 71348-45794 Shiraz, Iran.
Roberta ZuntiniShirin Farjadian, Department of Immunology, Allergy Research Center, Shiraz University of Medical Sciences, 71348-45794 Shiraz, Iran.
Simona FerrariShirin Farjadian, Department of Immunology, Allergy Research Center, Shiraz University of Medical Sciences, 71348-45794 Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis, a common autosomal recessive genetic disorder among Caucasians, is caused by defects in the transmembrane conductance regulatory (CFTR) gene. The analysis of CFTR gene mutations is useful to better characterize the disease, and for preconceptional screening, prenatal and preimplantation genetic diagnosis. Here we report the results of a genetic analysis in a 16-year-old boy from southwestern Iran diagnosed as having cystic fibrosis in infancy based on gastrointestinal and pulmonary manifestations, with positive sweat chloride tests. He lacked both normal and mutant forms of the fragment corresponding to the ∆F508 allele in initial genetic studies. Multiplex ligation-dependent probe amplification-based testing revealed a homozygous deletion spanning exons 4 to 10 of the CFTR gene. We predict an in-frame deletion removing 373 amino acids based on our sequencing results. Determining CFTR gene mutations in patients and their family members would be helpful to prevent the occurrence of new cases, especially in populations in which consanguinity is common.

Indexed as

Cystic fibrosisHomozygous deletionTransmembrane conductance regulatory gene

Identifiers

PMID25133155
PMCPMC4133434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.